High incidence of INR alteration in gastrointestinal cancer patients treated with mini-dose warfarin and 5-fluorouracil-based regimens.
Magagnoli
M
M
Masci
G
G
Castagna
L
L
Morenghi
E
E
Santoro
A
A
D000328:Adult; D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use*; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols; D002405:Catheterization, Central Venous / Q000009:adverse effects; D005472:Fluorouracil / Q000627:therapeutic use*; D005770:Gastrointestinal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D019934:International Normalized Ratio; D008875:Middle Aged; D011446:Prospective Studies; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control; D014859:Warfarin / Q000627:therapeutic use*
D000925:Anticoagulants; D000964:Antimetabolites, Antineoplastic; D014859:Warfarin; D005472:Fluorouracil